Cargando…
Overview of the molecular determinants contributing to the expression of Psoriasis and Psoriatic Arthritis phenotypes
Psoriasis and psoriatic arthritis are multifactorial chronic disorders whose etiopathogenesis essentially derives from the alteration of several signalling pathways and the co‐occurrence of genetic, epigenetic and non‐genetic susceptibility factors that altogether affect the functional and structura...
Autores principales: | Caputo, Valerio, Strafella, Claudia, Termine, Andrea, Dattola, Annunziata, Mazzilli, Sara, Lanna, Caterina, Cosio, Terenzio, Campione, Elena, Novelli, Giuseppe, Giardina, Emiliano, Cascella, Raffaella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754002/ https://www.ncbi.nlm.nih.gov/pubmed/33128843 http://dx.doi.org/10.1111/jcmm.15742 |
Ejemplares similares
-
Pharmacogenomics: An Update on Biologics and Small-Molecule Drugs in the Treatment of Psoriasis
por: Caputo, Valerio, et al.
Publicado: (2021) -
RNAseq-Based Prioritization Revealed COL6A5, COL8A1, COL10A1 and MIR146A as Common and Differential Susceptibility Biomarkers for Psoriasis and Psoriatic Arthritis: Confirmation from Genotyping Analysis of 1417 Italian Subjects
por: Caputo, Valerio, et al.
Publicado: (2020) -
Experimental Pharmacological Management of Psoriasis
por: Campione, Elena, et al.
Publicado: (2021) -
Shared (epi)genomic background connecting neurodegenerative diseases and type 2 diabetes
por: Caputo, Valerio, et al.
Publicado: (2020) -
A Real-Life Study on the Use of Tildrakizumab in Psoriatic Patients
por: Campione, Elena, et al.
Publicado: (2023)